Long-term survival rate of patients transfused with leucocyte-depleted and buffy-coat-poor blood during colorectal surgery: An eight-year follow-up study;Overlevelse efter transfusion med leukocytdepleteret og buffycoat-depleteret blod ved kolorektal kirurgi - Sekundærpublikation. Et otteårs post trial-opfølgningsstudie

Ugeskrift for Laeger

Volumn 168, Issue 5, 2006, Pages 481-484

  Jensen, Lone S ^a   Puho, Erzsebet ^a   Pedersen, Lars ^a   Mortensen, Frank V ^a   Sørensen, Henrik Toft ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BLOOD TRANSFUSION; COLORECTAL SURGERY; CONTROLLED STUDY; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; SURVIVAL RATE; SURVIVAL TIME; ADULT; AGED; APHERESIS; BACTERIAL INFECTION; CLINICAL TRIAL; COLORECTAL TUMOR; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; ERYTHROCYTE TRANSFUSION; FEMALE; LEUKAPHERESIS; MALE; MIDDLE AGED; MORTALITY; POSTOPERATIVE COMPLICATION; RANDOMIZED CONTROLLED TRIAL;

ADULT; AGED; AGED, 80 AND OVER; BACTERIAL INFECTIONS; BLOOD COMPONENT REMOVAL; COLORECTAL NEOPLASMS; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW-UP STUDIES; HUMANS; LEUKOCYTE REDUCTION PROCEDURES; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIALS; SURVIVAL RATE;

EID: 33644838693     PISSN: 00415782     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Jensen LS, Andersen AJ, Christiansen PM et al. Postoperative infection and natural killer cell function following blood transfusion in patients undergoing elective colorectal surgery. Br J Surg 1992;79:513-6.
2. Jensen LS, Kissmeyer-Nielsen P, Wollf B et al. Randomised comparison of leucocyte-depleted versus buffy-coat-depleted blood transfusion and complications after colorectal surgery. Lancet 1996;348:841-5.
3. Houbiers JGA, Brand A, van de Watering et al. Randomised controlled trial comparing transfusion of leucocyte-depleted or buffy-coat-depleted blood in surgery for colorectal cancer. Lancet 1994;344:573-8.
4. Van de Watering LMG, Brand A, Houbiers JGA et al. Perioperative blood transfusion, with or without allogeneic leucocytes, relate to survival, not to cancer recurrence. Br J Surg 2001;88:267-72.
5. Amato AC, Pescatori M. Effect of perioperative blood transfusion on recurrence of colorectal cancer. Meta-analysis stratified on risk factors. Dis Colon Rectum 1998;41:570-85.
6. Tartter P. The association of preoperative blood transfusion with colorectal cancer recurrence. Ann Surg 1992;216:633-8.
7. Heiss MM, Mempel W, Delanoff C et al. Blood transfusion-modulated tumor recurrence: first results of a randomized study of autologous vs allogeneic blood transfusion in colorectal cancer surgery. J Clin Oncol 1994;12:1859-67.
8. Mynster T, Christensen IJ, Moesgaard et al. Effects of the combination of blood transfusion and postoperative infectious complications on prognosis after surgery for colorectal cancer. Br J Surg 2000;87:1553-62.
9. Mynster T, Dybkjær E, Reimert CM et al. Prestorage leukofiltration of whole blood and SAGM blood prevents extracellular bioactive substance accumulation. Inflamm Res 1999;38:363-8.
10. Wong MP, Cheung N, Yuen ST et al. Vascular endothelial growth factor is up-regulated in the early pre-malignant stage of colorectal tumour progression. Int J Cancer 1999;81:845-50.